{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:20:17Z","timestamp":1763140817613,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.euf.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T04:46:11Z","timestamp":1445921171000},"page":"231-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pheochromocytoma in Urologic Practice"],"prefix":"10.1016","volume":"1","author":[{"given":"Nikhil","family":"Waingankar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennady","family":"Bratslavsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kutikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2015.09.011_bib0330","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euf.2015.09.011_bib0335","first-page":"802","article-title":"Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979","volume":"58","author":"Beard","year":"1983","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.euf.2015.09.011_bib0340","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0954-6820.1986.tb02755.x","article-title":"Pheochromocytoma in Sweden 1958\u20131981. An analysis of the National Cancer Registry Data","volume":"220","author":"Stenstrom","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.euf.2015.09.011_bib0345","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","article-title":"Secondary hypertension in a blood pressure clinic","volume":"147","author":"Sinclair","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.euf.2015.09.011_bib0350","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.euf.2015.09.011_bib0355","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-8529(05)70122-5","article-title":"Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota","volume":"29","author":"Young","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.euf.2015.09.011_bib0360","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2015.09.011_bib0365","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Amar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2015.09.011_bib0370","series-title":"Surgery of the Adrenal Glands","first-page":"187","article-title":"Pheochromocytoma","author":"Scott","year":"1990"},{"key":"10.1016\/j.euf.2015.09.011_bib0375","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1210\/jc.2003-031091","article-title":"Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma","volume":"89","author":"Ilias","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2015.09.011_bib0380","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2015.09.011_bib0385","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJM200205093461911","article-title":"Pheochromocytoma\u2013death of an axiom","volume":"346","author":"Dluhy","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2015.09.011_bib0390","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00268-004-7134-9","article-title":"Pheochromocytoma surgery: epidemiologic peculiarities in children","volume":"28","author":"Beltsevich","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.euf.2015.09.011_bib0395","doi-asserted-by":"crossref","first-page":"872713","DOI":"10.1155\/2012\/872713","article-title":"Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma\/paraganglioma","volume":"2012","author":"Parenti","year":"2012","journal-title":"J Oncol"},{"key":"10.1016\/j.euf.2015.09.011_bib0400","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2015.09.011_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)37119-7","article-title":"Extra-adrenal pheochromocytoma","volume":"147","author":"Whalen","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2015.09.011_bib0410","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jc.2010-1946","article-title":"Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators","volume":"96","author":"Ayala-Ramirez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2015.09.011_bib0415","unstructured":"DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. Pathology and Genetics: Tumours of Endocrine Organs, ed. 3. In: World Health Organization Classification of Tumours, vol. 8. Lyon, France: IARC Press; 2004."},{"key":"10.1016\/j.euf.2015.09.011_bib0420","series-title":"Surgery of the Adrenal Glands","article-title":"The adrenal medulla and adrenomedullary hormones","author":"Robertson","year":"1990"},{"key":"10.1016\/j.euf.2015.09.011_bib0425","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1748-1716.2007.01807.x","article-title":"A physiological view of the central and peripheral mechanisms that regulate the release of catecholamines at the adrenal medulla","volume":"192","author":"de Diego","year":"2008","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.euf.2015.09.011_bib0430","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.euf.2015.09.011_bib0435","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","author":"Pacak","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2015.09.011_bib0440","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ki.1991.244","article-title":"Pheochromocytoma: new concepts and future trends","volume":"40","author":"Bravo","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.euf.2015.09.011_bib0445","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005792-199101000-00004","article-title":"A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience","volume":"70","author":"Stein","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.euf.2015.09.011_bib0450","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.0.1500681","article-title":"Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients","volume":"150","author":"Baguet","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.euf.2015.09.011_bib0455","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1524-6175.2002.01452.x","article-title":"Pheochromocytoma","volume":"4","author":"Manger","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.euf.2015.09.011_bib0460","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/EJE-15-0456","article-title":"Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma","volume":"173","author":"Thosani","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.euf.2015.09.011_bib0465","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4158\/EP.14.9.1137","article-title":"Catecholamine-induced cardiomyopathy","volume":"14","author":"Kassim","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.euf.2015.09.011_bib0470","first-page":"511","article-title":"Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma","volume":"106","author":"Stenstr\u00f6m","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.euf.2015.09.011_bib0475","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2015.09.011_bib0480","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2015.09.011_bib0485","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12022-003-0012-4","article-title":"Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor","volume":"14","author":"Eisenhofer","year":"2003","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.euf.2015.09.011_bib0490","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/030089160509100110","article-title":"High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma","volume":"91","author":"Cotesta","year":"2005","journal-title":"Tumori"},{"key":"10.1016\/j.euf.2015.09.011_bib0495","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/cs0830205","article-title":"Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma","volume":"83","author":"Mouri","year":"1992","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.euf.2015.09.011_bib0500","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archinte.1992.00400180061009","article-title":"The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls","volume":"152","author":"Sjoberg","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.euf.2015.09.011_bib0505","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2015.09.011_bib0510","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/clinchem\/47.6.1061","article-title":"Quantification of unconjugated metanephrines in human plasma without interference by acetaminophen","volume":"47","author":"Roden","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.euf.2015.09.011_bib0515","first-page":"1685","article-title":"Pathophysiology, evaluation, and medical management of adrenal disorders","volume":"vol. 2","author":"Kutikov","year":"2012"},{"key":"10.1016\/j.euf.2015.09.011_bib0520","series-title":"Penn Clinical Manual of Urology","first-page":"769","article-title":"Disorders of the adrenal gland","author":"Kutikov","year":"2014"},{"key":"10.1016\/j.euf.2015.09.011_bib0525","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0009-9260(97)80252-8","article-title":"MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times","volume":"52","author":"Varghese","year":"1997","journal-title":"Clin Radiol"},{"key":"10.1016\/j.euf.2015.09.011_bib0530","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2015.09.011_bib0535","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12020-015-0544-7","article-title":"The incremental benefit of functional imaging in pheochromocytoma\/paraganglioma: a systematic review","volume":"50","author":"Brito","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.euf.2015.09.011_bib0540","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","article-title":"Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography","volume":"104","author":"Timmers","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2015.09.011_bib0545","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00259-013-2598-1","article-title":"Diagnostic accuracy of (68)Ga-DOTANOC PET\/CT imaging in pheochromocytoma","volume":"41","author":"Sharma","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euf.2015.09.011_bib0550","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2967\/jnumed.108.052373","article-title":"Comparison of 6\u201318F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma","volume":"49","author":"Ilias","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euf.2015.09.011_bib0555","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/HJH.0b013e32834d24d9","article-title":"Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary?","volume":"29","author":"Shao","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.euf.2015.09.011_bib0560","first-page":"617","article-title":"Current status of labetalol, the first alpha- and beta-blocking agent","volume":"23","author":"Kanto","year":"1985","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.euf.2015.09.011_bib0565","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0022-5347(01)61762-2","article-title":"Successful outcomes in pheochromocytoma surgery in the modern era","volume":"161","author":"Ulchaker","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2015.09.011_bib0570","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000658-199011000-00010","article-title":"Surgical management of pheochromocytoma with the use of metyrosine","volume":"212","author":"Perry","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/j.euf.2015.09.011_bib0575","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/EJE-11-0162","article-title":"Point of controversy: perioperative care of patients undergoing pheochromocytoma removal--time for a reappraisal?","volume":"165","author":"Lentschener","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.euf.2015.09.011_bib0580","doi-asserted-by":"crossref","unstructured":"Livingstone M, Duttchen K, Thompson J, et al. Hemodynamic stability during pheochromocytoma resection: lessons learned over the last two decades. Ann Surg Oncol. In press. http:\/\/dx.doi.org\/10.1245\/s10434-015-4519-y","DOI":"10.1245\/s10434-015-4519-y"},{"key":"10.1016\/j.euf.2015.09.011_bib0585","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.juro.2010.06.102","article-title":"Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup","volume":"184","author":"Benhammou","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2015.09.011_bib0590","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.03.046","article-title":"Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique","volume":"60","author":"Asher","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2015.09.011_bib0595","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.juro.2010.03.052","article-title":"Partial adrenalectomy: underused first line therapy for small adrenal tumors","volume":"184","author":"Kaye","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2015.09.011_bib0600","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1464-410X.2010.09568.x","article-title":"Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas","volume":"107","author":"Sanford","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2015.09.011_bib0605","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.urology.2010.07.501","article-title":"Robot-assisted laparoscopic partial adrenalectomy: initial experience","volume":"77","author":"Boris","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.euf.2015.09.011_bib0610","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/end.2013.0298","article-title":"Perioperative, functional, and oncologic outcomes of partial adrenalectomy for multiple ipsilateral pheochromocytomas","volume":"28","author":"Gupta","year":"2014","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2015.09.011_bib0615","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1530\/EJE-14-0113","article-title":"Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma","volume":"171","author":"Baudin","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.euf.2015.09.011_bib0620","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11912-013-0320-x","article-title":"Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma","volume":"15","author":"Jimenez","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.euf.2015.09.011_bib0625","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0031-1299707","article-title":"Metastatic pheochromocytoma and paraganglioma: focus on therapeutics","volume":"44","author":"Plouin","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.euf.2015.09.011_bib0630","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1210\/jc.2006-1544","article-title":"Clinical review: current treatment of malignant pheochromocytoma","volume":"92","author":"Scholz","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.euf.2015.09.011_bib0635","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score","volume":"33","author":"Wu","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euf.2015.09.011_bib0640","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/cncr.26577","article-title":"Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience","volume":"118","author":"Ayala-Ramirez","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2015.09.011_bib0645","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/cen.12341","article-title":"(131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis","volume":"80","author":"van Hulsteijn","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.euf.2015.09.011_bib0650","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1210\/jc.2012-2356","article-title":"Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas","volume":"97","author":"Ayala-Ramirez","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456915001534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456915001534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:45:30Z","timestamp":1762497930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456915001534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2405456915001534"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2015.09.011","relation":{},"ISSN":["2405-4569"],"issn-type":[{"type":"print","value":"2405-4569"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pheochromocytoma in Urologic Practice","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}